Timing of Surgery in Endocarditis - PowerPoint PPT Presentation

1 / 41
About This Presentation
Title:

Timing of Surgery in Endocarditis

Description:

No 'cookbook' approach to proper therapy, esp when considering surgery ... However, surgery carries risk and decision on whether or not to operate must be ... – PowerPoint PPT presentation

Number of Views:122
Avg rating:3.0/5.0
Slides: 42
Provided by: jimmyk
Category:

less

Transcript and Presenter's Notes

Title: Timing of Surgery in Endocarditis


1
Timing of Surgery in Endocarditis
  • Jimmy Klemis, MD
  • CT Surgery Conference

2
Endocarditis
  • Potentially lethal disease with varying
    etiologic agents and different clinical
    situations (NVE vs PVE, etc)
  • No cookbook approach to proper therapy, esp
    when considering surgery
  • In select patients, combined medical and surgical
    Rx offers substantial benefit compared with
    medical Rx alone
  • However, surgery carries risk and decision on
    whether or not to operate must be carefully
    thought out with good communication between
    surgical and medical teams

3
Endocarditis
  • In pre-Abx era, largely fatal disease
  • 1885 Sir William Osler in Gulstonian lectures
    referred to IE as the malignant endocarditis,
    30 years later he expressed pessimism about ever
    finding a cure for IE
  • 1940s PCN revived hope for a cure of IE,
    however morbidity and mortality only partially
    altered
  • resistant organisms and shifting etiology (IVDA)

Chamoun. Am J Med Sci. Oct 2000 320 (4)
4
Endocarditis surgical Rx
  • 1961 Kay et al first to report surgical cure of
    pt with medically resistant IE (fungal TV)
  • 1965 Wallace, et al first report of successful
    valve replacement in active endocarditis
  • early success in many studies of selected
    patients led to paradigm shift in management of
    complicated endocarditis

5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
Indications for Surgery
  • Hemodynamic compromise/ Heart failure
  • Persistent sepsis
  • Peripheral embolization
  • Extravalvular extension of infxn

9
Heart Failure
  • Mills, et al. UCSF 19741
  • 79/144 pt developed CHF within 6mos of admit
  • 60 moderate-severe
  • MR 50 developed CHF, 1/2 severe
  • AR 80 CHF, 2/3 severe
  • 6 month survival with severe CHF/AR
  • medical 7 med/surgical 64

1Mills J, et al. Chest 66151-157, 1974
10
CHF
  • Lewis, et al. Johannesburg, South Africa,
    1975-801
  • early valve replacement in 95 hemodynamically
    unstable pt 64 emergent 88 48hrs
  • Mortality
  • urgent surgery 15 (13/84)
  • elective 18 (2/11)
  • 5 year survival 60
  • Periprosthetic leaks in 13 (10/80) of survivors

1Lewis BS, et al. J Thorac Cardiovasc Surg
84579-84, 1982
11
CHF
  • Johannesburg, SA 1982-19881
  • 203pt with active IE and early valve replacement
  • Urgent surgery (lt48hrs) in 53
  • Mortality
  • Urgent 7
  • Overall 4
  • long term 6 pt followed 38 22mos

1Middlemost S, et al. JACC 18663-667, 1991
12
CHF Meta-analysis
Moon, et al. Prog Cardiovasc Dis. 1997
13
Persistent Sepsis
  • nonsterile Bld Cx 3-5d after dx
  • lack of improvement sxs after 1wk appropriate Abx
  • usually due to
  • Bacterial resistance
  • valvular/perivalvular infections
  • non cardiac septic foci (splenic, renal,
    cerebral abcess, mycotic aneurysm
  • GNR, staph or fungal infxn
  • surgery may eliminate septic focus, but not
    necessarily improve pt hemodynamic condition
    unless significant valvular regurg
  • Bld Cx at surgery predict adverse outcome

14
Persistent Sepsis
  • Postive Cx _at_ time of surgery predicts poorer
    outcome
  • DAgostino, et al Ann Thor Surg 1985
  • 108pt with NVE
  • 87pt Bld Cx (-) gt90 1 year complication free
    survival (no perivalvular leak, IE recurrence)
  • 19 pt Bld Cx () lt70

15
Persistent Sepsis
  • although ? complication if Bld Cx , still
    important to intervene esp in face of further
    destruction of valvular/annular tissue
  • Boyd, et al. NYU 19771
  • operative mortality risk in uncontrolled infxn
    better when operated earlier (within 10d of
    admit) (17) than when abx continued for 4-6wks
    (90)

1Boyd et al. J Thorac Cardiovasc Surg 7323-30,
1977
16
Persistent Sepsis/Surgery risk
Alsip et al, Am J Med 78138-148, 1985
17
Persistent Sepsis
  • may also be from extracardiac source/emboli
  • splenic, renal, cerebral abcesses
  • ? proper Rx surgery?, incidence of recurrent
    endocarditis in these situations?

18
Splenic abcess
Image Roberts, Cornell Univ Web SiteVascular
infections
19
Infectious etiology
  • S. aureus
  • highly destructive
  • meta-analysis showed higher mortality with
    medical (39/76 56 ) compared with med/surgical
    Rx (24/77 31 ) plt.03
  • not absolute indication but more aggressive
    surgical approach should be considered, esp if
    other factors
  • Gram (-)/serratia/pseudomonas

20
Infectious Etiology
  • Fungal
  • most common Aspergillus, Candida, Torulopsis
    glabrata
  • risk prev cardiac surgery, Abx use and
    hyperalimentation, long therm IV cath, IVDA
  • clinical neg Bld Cx/fever, changing murmur,
    chorioretinitis, and large peripheral emboli
  • overall survival with medical Rx 25 c/w
    med/surgical rx 58
  • compelling if not absolute indication for surgery

Rubenstein and Lang. Fungal Endocarditis. Eur
Heart J 1995
21
Peripheral Embolization
  • embolic events common 30-40 of IE
  • braingtlimbs, coronary, spleen, kidney
  • directly responsible for 25 of fatalities1
  • recurrence rate 54 within 30d
  • incidence falls after initiation of Abx therapy
    2wks
  • risk
  • size gt 10mm (47 vs 19)2
  • staph, candida, GNR
  • mobile, pedunculated, mitralgtaortic

1Acar, et al. Eur Heart J, 16 (supplement B),
94-98. 1995
2Mugge et al. JACC 14631-638. 1989
22
Moon, et al. Prog Cardiovasc Dis 1997
23
Vegetation on atrial surface of PMVL
24
Peripheral Embolization
  • Rohmann, et al1
  • 64 vegetations resolved/decreased
  • 36 no change/increased
  • valve replacement 2 vs 45
  • perivalvular abcess 2vs 13
  • mortality 0 vs 10
  • Vuille, et al2
  • persistent veg in 50 despite clinical healing,
    no independent association with late
    complications
  • in the absence of valvular dysfxn, persistent
    vegetation on echo shouldnt be criterion for
    valve replacement in absence of other indications

1Rohmann, et al. J Am Soc Echo 4465-474, 1991
2Vuille, et al. Am Heart J 128 1200-1209. 1994
25
Peripheral Embolization
  • recurrent emboli are relative indication for
    surgery (class IIa) but should not be considered
    absolute indication

26
Emboli Cerebral (Con)
  • surgical intervention with cardiopulm bypass can
    cause extension of infarct or hemorrhagic
    transformation of previously bland infarct
  • Eishi et al cerebral emboli surgery

Eishi, et al. J Thorac Cardiovasc Surg
1101745-1755, 1995
27
Fig. 1. Computed tomographic scans of a patient
with right middle cerebral artery infarction
resulting from infective endocarditis. This
patient underwent a Bentall-type operation for
graft infection on the same day, resulting in
massive brain swelling, and died 3 days later.
Top row, Preoperative computed tomographic
scans bottom row, postoperative scans.
Eishi,et al. J Thorac Cardiovasc Surg
19951101745-55
28
Emboli Cerebral (Pro)
  • Ting, et al smaller, bland cerebral infarcts
    31pt1
  • operative mortality 19
  • survivors (81)
  • 5pt with cerebral hemorrhage ? CVA
  • others
  • 12 exacerbated CNS sxs
  • 16 unchanged
  • 20 partial resolution
  • 52 complete resolution
  • Other studies have shown complete neurologic
    recovery in pt with coma or dense hemiparesis
    after valve replacement, but recommended delay if
    bleed2

1Ting, et al. Ann Thorac Surg 5118-22, 1991
2Zisbrod, et al. Circulation 76V109-V112, 1987
(suppl V)
29
Ruptured mycotic aneurysm in MCA territory
(causative agent Aspergillus)
30
Emboli - Cerebral
  • single cerebral embolus not indication for
    surgery unless assoc with large mobile veg and
    that further CNS injury might preclude
    meaningful chance at recovery/rehabilitation
  • bland infarct if stable hemodynamics, 2-3 wks
    Abx before considering surgery to minimize
    provoking further CNS injury
  • hemorrhagic infarct surgery postponed as long
    as possible optimally if full course Abx can be
    given and recovery of neurologic dysfxn

31
Extravalvular Extension
  • annular abscess
  • operative mortality 19-43 (vs gt75 medically
    treated)1
  • extensive tissue necrosis/structural damage
    including interventricular septum, conduction
    system, and fibrous skeleton of heart
  • In NVE mitral (1-5) lt aortic (25-50)
  • clinically have more valvular regurgitation
  • hi risk (staph/fungal, new heart block, PVE)
    should undergo TEE (90 detection vs 50 TTE)

1Moon, et al. Prog Cardiovasc Dis 1997 Nov-Dec
40(3) p246
32
  • ECHO findings in Annular abscess
  • anterior or posterior Ao root wall thickness
    10mm
  • perivalvular density in IVS 14mm
  • sinus of valsalva defect/aneurysm
  • rocking of prosthetic valve
  • Sens and Spec 85 if 1 of above seen

33
Cormier et al. Eur Heart J 1995 (16) suppl B 68-71
34
TTE (L) and TEE (R) showing evidence of AV
vegetation and paravalvular abscess
Otto. Textbook of Clinical Echocardiography 2nd
Ed. Chp 13
35
communicating Ao root abscess
Dec 2001 ECHO case of the month, www.acc.org
36
Extravalvular Extension
  • Conduction disturbances in 30 with abscess vs
    lt2 if no abscess
  • 1st degree gt 7d, new 2nd or 3rd degree block
    requires eval for abcess - TEE

37
Meta-analysis
Moon, et al. Prog Cardiovasc Dis. 1997
38

Moon, et al. Prog Cardiovasc Dis 1997
39
Predictors of operative mortality
Moon, et al. Prog Cardiovasc Dis 1997
40
Conclusions
  • Combined medical/surgical rx of selected
    populations offers substantial morbidity and
    mortality benefit.
  • careful attention to hemodynamic status,
    infecting organism (staph aureus, fungi, GNR),
    valve(s) involved (AV), clinical manifestations
    (emboli, abscess, conduction abnl, CHF), and
    findings on imaging (TTE/TEE, etc) allow a
    tailored approach to proper Rx in each patient to
    minimize morbidity and mortality

41
Conclusions
Write a Comment
User Comments (0)
About PowerShow.com